Literature DB >> 7218597

Safe limit of hemodilution in cardiopulmonary bypass -comparative analysis between cyanotic and acyanotic congenital heart disease.

M Kawamura, O Minamikawa, H Yokochi, S Maki, T Yasuda, Y Mizukawa.   

Abstract

A safe limit of hemodilution in cardiopulmonary bypass (CPB) for open heart surgery was investigated by analyzing of the perfusion results of 100 patients with tetralogy of Fallot (TOF) and ventricular septal defect (VSD). The higher perfusion flow was necessary to compensate for the reduced oxygen carrying capacity and to maintain adequate arterial pressure in proportion to the increase in hemodilution. Once the dilution ratio reached over 40% in TOF and 50% in VSD, however, adequate oxygen transfer and stable hemodynamic conditions could not be maintained. The former was due to inadequate oxygen delivery and the latter to an impaired venous return. In these cases, various complications caused by residual diluent in the body space despite of extensive diuretic therapy occurred immediately postop. The safe limit of hemodilution is 50%. However, that of cyanotic disease, even in the presence of remarkable polycythemia, must be limited to less than 40%.

Entities:  

Mesh:

Year:  1980        PMID: 7218597     DOI: 10.1007/bf02468749

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  15 in total

1.  Surgical aspects of regional myocardial blood flow and myocardial pressure.

Authors:  R J Baird; F Dutka; M Okumori; A de la Rocha; M M Goldbach; T J Hill; D C MacGREGOR
Journal:  J Thorac Cardiovasc Surg       Date:  1975-01       Impact factor: 5.209

2.  Effects of hemodilution on hypotention during cardiopulmonary bypass.

Authors:  R J Gordon; M Ravin; G R Daicoff; R E Rawitscher
Journal:  Anesth Analg       Date:  1975 Jul-Aug       Impact factor: 5.108

3.  Respiratory insufficiency following open heart surgery.

Authors:  J J OSBORN; R W POPPER; W J KERTH; F GERBODE
Journal:  Ann Surg       Date:  1962-10       Impact factor: 12.969

4.  Transfusion-associated hepatitis not due to viral hepatitis type A or B.

Authors:  S M Feinstone; A Z Kapikian; R H Purcell; H J Alter; P V Holland
Journal:  N Engl J Med       Date:  1975-04-10       Impact factor: 91.245

5.  On the availability of oxygen to the body during cardiopulmonary bypass in man.

Authors:  E A Harris; E R Seelye; B G Barratt-Boyes
Journal:  Br J Anaesth       Date:  1974-06       Impact factor: 9.166

6.  Safe limits of hemodilution in cardiopulmonary bypass.

Authors:  Y Kawashima; Z Yamamoto; H Manabe
Journal:  Surgery       Date:  1974-09       Impact factor: 3.982

7.  Open-heart surgery in Jehovah's Witnesses: experience in a Canadian hospital.

Authors:  P V Kamat; C B Baker; J K Wilson; D C Finlayson
Journal:  Ann Thorac Surg       Date:  1977-04       Impact factor: 4.330

8.  The influence of coronary arterial pH on myocardial oxygen demand.

Authors:  A H Harken; M Woods
Journal:  Surgery       Date:  1977-06       Impact factor: 3.982

9.  High-flow total body perfusion with severe hemodilution and normothermia in infants weighing less than 10 kg--safe limits of hemodilution in cardiopulmonary bypass in infants.

Authors:  M Kawamura; K Sakakibara; O Minamikawa; H Yokochi; A Kobayashi
Journal:  Jpn J Surg       Date:  1977-06

10.  Anesthesia and postoperative care for cardiac operations.

Authors:  S Tarhan; R D White; E A Moffitt
Journal:  Ann Thorac Surg       Date:  1977-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.